EZH2 and keratoconus: Consistently, the expression of p53 and its downstream target p21 was not increased in KEC vs. KC PDAC (Figure 6G), suggesting that PDAC that evolves despite the absence of Ezh2 bypasses upregulation of p19Arf expression and subsequent stabilization of p53wt in favour of a progressive tumor phenotype.